Luxcel Biosciences, an Ireland-based cellular research services spinout from University College Cork (UCC), was acquired by scientific diagnostics firm Agilent Technologies for an undisclosed sum on Tuesday.
Founded in 2002, Luxcel tests cell cultures to establish oxygen concentration, drug toxicity and cell metabolism. Cell metabolism alterations can be indicative of malignant and cancerous transformations.
The tests are offered to research labs and are performed from treatment apparatus rather than from within organisms, a model known as in vitro.
Luxcel’s 12-person…
